{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:39:14Z","timestamp":1762875554514},"reference-count":14,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.3201\/eid\/1706.101037","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T18:33:38Z","timestamp":1378492418000},"page":"1099-1102","source":"Crossref","is-referenced-by-count":44,"title":["High Vancomycin MIC and Complicated Methicillin-Susceptible<i>Staphylococcus aureus<\/i>Bacteremia"],"prefix":"10.3201","volume":"17","author":[{"given":"Jose Maria","family":"Aguado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"San-Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lalueza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Rodr\u00edguez-Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"G\u00f3mez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid\/1706.101037-201309061432-R1","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R2","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"51","author":"Moise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R3","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3201\/eid0906.030001","article-title":"Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia.","volume":"9","author":"Schwaber","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1086\/605636","article-title":"Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.","volume":"49","author":"Pillai","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.","volume":"39","author":"Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/649572","article-title":"Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?","volume":"201","author":"Lalueza","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R10","unstructured":"Lalueza A, Chaves F, San Juan R, Daskalaki M, L\u00f3pez-Medrano M, Lizasoain M, Less severity but higher risk of late complications in methicillin-resistantStaphylococcus aureusbacteremia with a vancomycin MIC \u22651.5 \u00b5g\/mL. In: Microbiology ASF, editor. 49th Interscience Conference on Antimicrobials Agents and Chemotherapy. San Francisco: American Society for Microbiology; 2009."},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.","volume":"41","author":"Cui","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1086\/596511","article-title":"Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.","volume":"199","author":"Peleg","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid\/1706.101037-201309061432-R14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1086\/502519","article-title":"Epidemiology and clonality of methicillin-resistant and methicillin-susceptible Staphylococcus aureus causing bacteremia in a tertiary-care hospital in Spain.","volume":"26","author":"Chaves","year":"2005","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T21:28:49Z","timestamp":1498080529000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/17\/6\/10-1037_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid\/1706.101037","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}